Loading
institutionsInstitution
Cleveland Clinic Taussig Cancer Institute
Cleveland Clinic is a top US hospital with a Comprehensive Cancer Center (with Case Western) and a TNBC preventive vaccine programme.
Overview
Cleveland Clinic Taussig Cancer Institute is the cancer arm of a top US hospital, NCI-designated as comprehensive through its partnership in the Case Comprehensive Cancer Center with Case Western, and twentieth in the Newsweek/Statista oncology ranking. It is best known in OnCo for Vincent K. Tuohy's alpha-lactalbumin preventive vaccine for triple-negative breast cancer, which is in phase 1, and for strengths in genitourinary oncology and haematology, with Eric A. Klein, Jaroslaw P. Maciejewski and Jame Abraham among its people. OnCo links it to work on bariatric surgery and cancer incidence, to the idea of joining bariatric and GLP-1 registries to cancer registries, and to Cleveland Clinic Abu Dhabi and the Ellison Institute of Technology. Whether a preventive vaccine can be proved in healthy women is the open question its flagship programme faces. Its programmes are listed below.
Location
Cleveland, US
Type
hospital
Newsweek 2026 oncology rank
#20
NCI designation
comprehensive
OnCo score
#26 · 81 points (40 Newsweek + 15 NCI + 26 from 13 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Cleveland Clinic, including child institutions. 2,275 works · 29,951 citations · 59% open access · 10% clinical trials · 2% reviews.
Oncology works per year
4412022
4772023
5172024
5302025
3102026
Most works
- Steven D. Wexner123 works
- Sameh Hany Emile113 works
- Zoe Garoufalia86 works
- Brian Thomas Hill81 works
- Nir Horesh80 works
- Faiz Anwer67 works
- Danai Dima60 works
- Emre Görgün58 works
- Jack Khouri57 works
- Rachel Gefen54 works
Most cited
- TNBC preventive vaccine
- GU oncology
- Haematology
Eric A. Klein
Emeritus Professor and Chairman, Glickman Urological and Kidney Institute, Cleveland Clinic; Distinguished Scientist, GRAIL
Multi-cancer early detectionProstate cancerGenomic classifiers
Urologist who led the CCGA study validating the Galleri methylation-based multi-cancer detection test.
Jame Abraham
Chair, Department of Hematology and Medical Oncology
Breast cancerClinical trialsCancer care delivery
Jame Abraham leads medical oncology at Cleveland Clinic and its breast cancer trial programme.
Jaroslaw P. Maciejewski
Chair, Department of Translational Hematology and Oncology Research
Myelodysplastic syndromesBone marrow failureClonal haematopoiesis
Jaroslaw Maciejewski is a leukaemia geneticist who defined the mutational landscape of myelodysplastic syndromes.
Justin D. Lathia
Melvin H. Burkhardt Endowed Chair for Neuro-Oncology Clinical Research; Vice Chair, Cardiovascular and Metabolic Sciences
Glioblastoma stem cellsSex differences in cancerTumour microenvironment
Justin Lathia studies glioblastoma stem cells and why brain tumours differ between men and women.
Larry Ellison
Oracle founder behind the Ellison Institute for Transformative Medicine and the Ellison Institute of Technology
Cancer care redesignResearch institute buildingTechnology and medicine
In 2016 he founded an institute in Los Angeles to reimagine cancer care, and his Ellison Institute of Technology is building an Oxford campus with a £130 million alliance with the university.
Nathan A. Pennell
Vice Chair of Clinical Research, Taussig Cancer Institute; Lung Cancer Medical Oncology Program
Lung cancerBiomarker testingClinical research operations
Lung cancer oncologist who has pushed for universal biomarker testing and better trial design.
Shilpa Gupta
Director, Genitourinary Medical Oncology
Bladder cancerKidney cancerImmunotherapy trials
Genitourinary oncologist leading bladder and kidney cancer trials and national guideline work.
Timothy A. Chan
Director, Global Center for Immunotherapy; Chair, Center for Immunotherapy and Precision Immuno-Oncology
ImmunogenomicsTumour mutational burdenHLA and immunotherapy response
Timothy Chan showed that tumour mutational burden predicts who benefits from checkpoint inhibitors.
Vincent K. Tuohy
Mort and Iris November Distinguished Chair in Innovative Breast Cancer Research, Lerner Research Institute
Preventive cancer vaccinesAlpha-lactalbuminTriple-negative breast cancer
Vincent Tuohy invented a preventive vaccine against triple-negative breast cancer, now in early human trials.
Similar pages
- CompanyMevion Medical Systems
Shares Case Comprehensive Cancer Center, Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy.
- InstitutionGeorgetown Lombardi Comprehensive Cancer Center
Shares Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS), Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, National Cancer Institute (NIH).
- InstitutionThe University of Kansas Cancer Center
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, National Cancer Institute (NIH), Triple-negative breast cancer (TNBC).
- InstitutionSamsung Medical Center
Shares Gamma Knife, Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS), Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy.
- InstitutionApollo Hospitals (Apollo Cancer Centres)
Shares Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS), Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy.
- PersonGeorges-Pascal Haber
- InstitutionSylvester Comprehensive Cancer Center, University of Miami
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, National Cancer Institute (NIH).
- TechnologyGLP-1 receptor agonists and obesity-related cancer risk
Shares Link bariatric and GLP-1 registries to cancer registries in every country that has both, Bariatric surgery and cancer incidence, Renal cell carcinoma.
cancers
technologies
institutions
ideas
people
Software in use
The software of oncology →Commercial and regulated products that this organisation sells. Each card says what is behind it: a regulator's database, the literature, a public body's list, or only the company's own words. Listing is not endorsement, and a clearance is a regulatory fact, not a clinical one.
A hospital's own remote second opinion service: records and imaging are collected, a specialist reviews them and writes an opinion.
Cleveland Clinic Taussig Cancer Instituteno source outside the company found